Neyagawa, Japan

Yoshiro Nishimura


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 58(Granted Patents)


Location History:

  • Neyagawa, JP (1982)
  • Suita, JP (1985)

Company Filing History:


Years Active: 1982-1985

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yoshiro Nishimura: Innovator in Antibacterial Compounds

Introduction

Yoshiro Nishimura is a notable inventor based in Neyagawa, Japan. He has made significant contributions to the field of antibacterial compounds, holding a total of four patents. His work focuses on the development of naphthyridine derivatives, which have important applications in antibacterial compositions.

Latest Patents

Nishimura's latest patents include the invention of 7-(4-Pyridyl)-1,8-naphthyridine derivatives and their antibacterial properties. One of his notable patents describes a 7-(4-pyridyl)-1,8-naphthyridine compound, where R1 can be a hydrogen atom, an ethyl or vinyl group, and R2 can be a hydrogen atom or a lower alkyl group with 1 to 6 carbon atoms. These compounds are useful in creating antibacterial compositions or as intermediates in their production. Another patent focuses on 1,8-naphthyridine compounds, particularly those containing halogen atoms, especially fluorine, which are also valuable in antibacterial applications.

Career Highlights

Throughout his career, Yoshiro Nishimura has worked with prominent companies, including Dainippon Pharmaceutical Company, Limited and Laboratoire Roger Bellon. His experience in these organizations has contributed to his expertise in the development of pharmaceutical compounds.

Collaborations

Nishimura has collaborated with notable colleagues such as Jun-ichi Matsumoto and Yoshiyuki Takase. These partnerships have likely enhanced his research and development efforts in the field of antibacterial agents.

Conclusion

Yoshiro Nishimura's innovative work in the field of antibacterial compounds has led to the development of several important patents. His contributions continue to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…